Atlas Trials

Newish Technology (Beijing) Co., Ltd.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Newish Technology (Beijing) Co., Ltd.

RecordFirmDate
NWRD06 DNA Plasmid for HCC After Curative Resection. (NCT07324304)Newish Technology (Beijing) Co., Ltd.2025-12-08
NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. (NCT06741150)Newish Technology (Beijing) Co., Ltd.2024-06-24
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer (NCT07092007)Newish Technology (Beijing) Co., Ltd.2024-06-05
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL (NCT06276101)Newish Technology (Beijing) Co., Ltd.2024-05-07
NWRD06 DNA Plasmid for HCC After Radical Resection (NCT06088459)Newish Technology (Beijing) Co., Ltd.2023-11-01
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection (NCT05352646)Newish Technology (Beijing) Co., Ltd.2022-07-26
Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive (NCT05905354)Newish Technology (Beijing) Co., Ltd.2022-03-07
Clinical Trial of Autologous Tcm Immunotherapy in ICC (NCT03820310)Newish Technology (Beijing) Co., Ltd.2018-05-01

Track Newish Technology (Beijing) Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.